Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Presentation TCT 2018

The Vulnerable Plaque and Patient Revisited: Whole-Heart Quantitation and Characterization of Atherosclerosis by CT

Presenter: James K. Min, Todd C. Villines, Paul Knaapen

September 23, 2018

Presentation TCT 2018

FFR-CT: An Evidence-Based Appraisal

Presenter: James K. Min, Todd C. Villines

September 23, 2018

Presentation TCT 2018

CT as First-line Test for Everyone With Suspected CAD: Rationale Behind the NICE Guidelines

Presenter: James K. Min, Todd C. Villines

September 23, 2018

Presentation TCT 2018

New CT Insights for TMVR: The NeoLVOT and Skirt Neo-LVOT Concept

Presenter: James K. Min, Todd C. Villines, Victoria Delgado

September 23, 2018

Presentation TCT 2018

Is Post-TAVR CT Imaging Just as Important as Pre-TAVR CT Imaging? Focus on HALT

Presenter: James K. Min, Todd C. Villines, Hasan Jilaihawi

September 23, 2018

News Conference News ESC 2018

FFRCT Shifts Patient Management, Linked to Better 90-Day Outcomes: ADVANCE Registry

Caitlin E. Cox

September 07, 2018

News Conference News ESC 2018

SCOT-HEART: A Win for CT Angiography in Chest Pain Workup Prompts Cacophony of Reactions

Shelley Wood

August 31, 2018

News Industry News

New Real-World Analysis Finds Lower Risk of Major Bleeding and Similar Risk of Stroke with Standard Dose of Pradaxa® Compared to Rivaroxaban in NVAF Patients Newly Initiating Treatment

January 29, 2018

News Conference News ISC 2018

More Evidence Rivaroxaban May Carry Higher Bleeding Risk Than Other NOACs

Todd Neale

January 27, 2018

Advertisement

The Vulnerable Plaque and Patient Revisited: Whole-Heart Quantitation and Characterization of Atherosclerosis by CT

FFR-CT: An Evidence-Based Appraisal

CT as First-line Test for Everyone With Suspected CAD: Rationale Behind the NICE Guidelines

New CT Insights for TMVR: The NeoLVOT and Skirt Neo-LVOT Concept

Is Post-TAVR CT Imaging Just as Important as Pre-TAVR CT Imaging? Focus on HALT

FFRCT Shifts Patient Management, Linked to Better 90-Day Outcomes: ADVANCE Registry

SCOT-HEART: A Win for CT Angiography in Chest Pain Workup Prompts Cacophony of Reactions

New Real-World Analysis Finds Lower Risk of Major Bleeding and Similar Risk of Stroke with Standard Dose of Pradaxa® Compared to Rivaroxaban in NVAF Patients Newly Initiating Treatment

More Evidence Rivaroxaban May Carry Higher Bleeding Risk Than Other NOACs

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content